Gables Capital Management Inc. Gilead Sciences, Inc. Transaction History

Gables Capital Management Inc.

$195 Million
Q3 2024

A detailed history of Gables Capital Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gables Capital Management Inc. holds 4,450 shares of GILD stock, worth $398,319. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,450

Previous 5,185 14.18%

Holding current value

$398,319

Previous $355,000 4.79%

% of portfolio

0.19%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $48,943 - $61,732	-735 Reduced 14.18%	4,450 $372,000
Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $53,677 - $61,947	-850 Reduced 14.08%	5,185 $355,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $32,211 - $39,280	-450 Reduced 6.94%	6,035 $442,000
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $3,663 - $4,154	-50 Reduced 0.77%	6,485 $525,000
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $44,364 - $48,402	-600 Reduced 8.41%	6,535 $489,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $6,460 - $7,369	85 Added 1.21%	7,135 $549,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $6,232 - $8,947	100 Added 1.44%	7,050 $605,000
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 1.42%	6,950 $429,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $2,896 - $3,629	-50 Reduced 0.7%	7,050 $419,000
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $45,416 - $51,548	-700 Reduced 8.97%	7,100 $516,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $103,227 - $111,370	-1,525 Reduced 16.35%	7,800 $545,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $250,008 - $273,169	-3,939 Reduced 29.7%	9,325 $642,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $21,735 - $27,328	-350 Reduced 2.57%	13,264 $838,000
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $12,370 - $14,364	171 Added 1.27%	13,614 $1.05 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $3,382 - $4,331	54 Added 0.4%	13,443 $1.01 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $30,810 - $33,890	500 Added 3.88%	13,389 $866,000
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $6,187 - $6,938	-100 Reduced 0.77%	12,889 $869,000
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $106,301 - $119,085	-1,700 Reduced 11.57%	12,989 $844,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $42,378 - $55,300	-700 Reduced 4.55%	14,689 $919,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $28,512 - $31,568	-400 Reduced 2.53%	15,389 $0
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $32,439 - $37,840	-500 Reduced 3.07%	15,789 $1.1 Million
Q1 2018 May 17, 2018	BUY	$72.84 - $88.8 $1.19 Million - $1.45 Million	16,289 New	16,289 $1.23 Million

Others Institutions Holding GILD

# of Institutions

1,903

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Gilead Sciences, Inc. Transaction History